{'fraction_non_alphanumeric': 0.05977229601518026, 'fraction_numerical': 0.06261859582542695, 'mean_word_length': 4.2227722772277225, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Studies on Binding Sites of Myeloma Proteins


 Mouse IgA myeloma protein S-183 detected as binding the 3-nitro-4-hydroxyl-5-iodophenylacetyl (NIP) groups by precipitation of NIP-protein conjugate, was specifically purified on a NIP-immunoadsorbent (NIP-poly-RSA). The purified protein binds 2 moles NIP-ε-aminocaproate/150,000 g protein with a binding constant (K0) of ∼5.5 × 103 M-1. Fab fragments of specifically purified S-183 have one specific NIP-binding site/50,000 g protein, K0 ≈ 3.1 × 103 M-1. The binding sites on S-183 Fab contain arginyl residues, as do those of conventionally induced rabbit anti-NIP antibodies, as shown by loss of binding sites when 63% of S-183 Fab arginine is glyoxalated. Some protection of the sites from glyoxalation is afforded by 0.1 M NIP. Evidence for the degree of specificity of the S-183 sites for NIP obtains from comparison with NIP binding by MOPC-315 mouse IgA myeloma protein (K0 ∼2 × 103 M-1) which does not precipitate with NIP-protein and by several human IgG myeloma proteins (K0 ∼0.3–0.7 × 103 M-1).